Serum HMGB3 and PCSK9 Levels as Predictors of Early Treatment Response in Pediatric Mycoplasma pneumoniae Pneumonia: A Single-Center Prospective Cohort Study
Objective To investigate the predictive value of serum high mobility group box 3 (HMGB3) and proprotein convertase subtilisin/kexin type 9 (PCSK9) levels for poor early treatment response in pediatric Mycoplasma pneumoniae pneumonia (MPP). Methods A total of 400 pediatric patients with Mycoplasma pneumoniae pneumonia (...